CCM
TSVT

Camber Capital Management’s 2seventy bio TSVT Stock Holding History

Camber Capital Management’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-48,600
Closed -$642K – 49
2022
Q2 		$642K Buy
+48,600
New +$662K 0.03% 40

Other funds holding TSVT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

Camber Capital Management's TSVT Position: Q3 2022 in Review

Camber Capital Management sold out of 2seventy bio (TSVT) in Q3 2022, closing a stake of 48,600 shares — an estimated $642K sold.

Camber Capital Management first reported a position in TSVT in Q2 2022 and held it in 1 quarter. The position peaked at $642K in Q2 2022. 133 funds tracked by Wall St. Rank hold TSVT as of Q3 2022.

  • Camber Capital Management reported no remaining 2seventy bio position as of Q3 2022 after selling out during the quarter.
  • Camber Capital Management sold 48,600 2seventy bio shares in Q3 2022, an estimated $642K.
  • Camber Capital Management first reported a position in 2seventy bio in Q2 2022 and held it in 1 quarter.
  • Camber Capital Management's 2seventy bio position peaked at $642K in Q2 2022.
  • 133 funds tracked by Wall St. Rank held 2seventy bio as of Q3 2022.

Based on Camber Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.